Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slack

Showing results (401-410 of 472) with videos related to

Pageof 48
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Personalized RNA Medicine for Pancreatic CancerMaud-Emmanuelle Gilles, Liangliang Hao, Ling Huang, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer riskCory Pelletier, William C Speed, Trupti Paranjape, et al.
Frontiers in Pharmacology|August 15, 2024
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitisPaolo Comeglio, Giulia Guarnieri, Sandra Filippi, et al.
Cancer Research|December 18, 2015
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast CancerBrian D Adams, Vikram B Wali, Christopher J Cheng, et al.
European Journal of Pharmacology|November 11, 2024
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liverAlison C MacKinnon, Duncan C Humphries, Kimberley Herman, et al.
Chemmedchem|June 18, 2019
The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 AntagonistsRichard J D Hatley, Tim N Barrett, Robert J Slack, et al.
Alimentary Pharmacology & Therapeutics|April 13, 2013
Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkersA J Slack, M J W McPhail, M Ostermann, et al.
ACS Applied Materials & Interfaces|December 16, 2023
Comparative Studies of Atomically Thin Proton Conductive Films to Reduce Crossover in Hydrogen Fuel CellsShanmukh Kutagulla, Nam Hoang Le, Isabel Terry Caldino Bohn, et al.
Nature|November 20, 2014
MicroRNA silencing for cancer therapy targeted to the tumour microenvironmentChristopher J Cheng, Raman Bahal, Imran A Babar, et al.
Cell Cycle (Georgetown, Tex.)|May 6, 2011
MicroRNA signatures differentiate melanoma subtypesElcie Chan, Rajeshvari Patel, Sunitha Nallur, et al.
Pageof 48

Showing results (401-410 of 472) with videos related to

Sort By:
Pageof 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Personalized RNA Medicine for Pancreatic CancerMaud-Emmanuelle Gilles, Liangliang Hao, Ling Huang, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer riskCory Pelletier, William C Speed, Trupti Paranjape, et al.
Frontiers in Pharmacology|August 15, 2024
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitisPaolo Comeglio, Giulia Guarnieri, Sandra Filippi, et al.
Cancer Research|December 18, 2015
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast CancerBrian D Adams, Vikram B Wali, Christopher J Cheng, et al.
European Journal of Pharmacology|November 11, 2024
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liverAlison C MacKinnon, Duncan C Humphries, Kimberley Herman, et al.
Chemmedchem|June 18, 2019
The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 AntagonistsRichard J D Hatley, Tim N Barrett, Robert J Slack, et al.
Alimentary Pharmacology & Therapeutics|April 13, 2013
Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkersA J Slack, M J W McPhail, M Ostermann, et al.
ACS Applied Materials & Interfaces|December 16, 2023
Comparative Studies of Atomically Thin Proton Conductive Films to Reduce Crossover in Hydrogen Fuel CellsShanmukh Kutagulla, Nam Hoang Le, Isabel Terry Caldino Bohn, et al.
Nature|November 20, 2014
MicroRNA silencing for cancer therapy targeted to the tumour microenvironmentChristopher J Cheng, Raman Bahal, Imran A Babar, et al.
Cell Cycle (Georgetown, Tex.)|May 6, 2011
MicroRNA signatures differentiate melanoma subtypesElcie Chan, Rajeshvari Patel, Sunitha Nallur, et al.
Pageof 48